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Escherichia coli RecG functionally suppresses
human Bloom syndrome phenotypes
Michael W Killen1,2, Dawn M Stults3, William A Wilson4 and Andrew J Pierce1,5*
Abstract
Defects in the human BLM gene cause Bloom syndrome, notable for early development of tumors in a broad
variety of tissues. On the basis of sequence similarity, BLM has been identified as one of the five human homologs
of RecQ from Escherichia coli. Nevertheless, biochemical characterization of the BLM protein indicates far greater
functional similarity to the E. coli RecG protein and there is no known RecG homolog in human cells. To explore the
possibility that the shared biochemistries of BLM and RecG may represent an example of convergent evolution of
cellular function where in humans BLM has evolved to fulfill the genomic stabilization role of RecG, we determined
whether expression of RecG in human BLM-deficient cells could suppress established functional cellular Bloom
syndrome phenotypes. We found that RecG can indeed largely suppress both the definitive elevated sister
chromatid exchange phenotype and the more recently demonstrated gene cluster instability phenotype of
BLM-deficient cells. In contrast, expression of RecG has no impact on either of these phenotypes in human cells
with functional BLM protein. These results suggest that the combination of biochemical activities shared by RecG
and BLM fill the same evolutionary niche in preserving genomic integrity without requiring exactly identical
molecular mechanisms.
Background
Human cells possess five proteins with clear sequence
homology to the E. coli RecQ protein: BLM, WRN,
RECQL, RECQL4 and RECQL5. These proteins are all
implicated in preserving genomic integrity (reviewed in
[1,2]). Functionally, inherited homozygous defects in
BLM, WRN or RECQL4 cause human disease: Bloom
syndrome, Werner syndrome and Rothmund-Thomson/
RAPADILINO/Baller-Gerold syndromes respectively.
Bloom syndrome is particularly striking for its predis-
position to early-onset malignancy with a broad distribu-
tion of cancer types similar to that seen with sporadic
tumors in the general population [3].
Sequence homology of BLM with RecQ notwithstand-
ing, characterization of the in vitro activities of BLM
demonstrates significant similarities to the biochemistry
of the E. coli RecG DNA translocase protein. Both BLM
[4,5] and RecG [6,7] can bind to and regress multi-
stranded DNA structures that model stalled replication
forks. Similarly, both BLM [8,9] and RecG [10,11] have
the capacity to bind to and branch migrate Holliday
junctions. Both BLM [12,13] and RecG [14] have also
been shown to dismantle D-loops where a 30-OH ssDNA
has invaded a homologous DNA duplex, although the
mechanism by which RecG carries out this reaction is
less well established [15]. The manner by which RecG
accomplishes these tasks is in large part made clear by
its crystal structure [16]: a RecG monomer binds at a
model replication fork by inserting a C-terminal protein
wedge domain into the fork. The body of RecG then
functions as a double stranded DNA translocase to pull
on and reanneal DNA template strands through the
body of the protein. At such time as the nascent DNA
strands encounter the wedge domain, they are stripped
off and allowed to anneal together resulting in the for-
mation of a Holliday junction. As RecG continues to
translocate on the dsDNA, the branch point of the
Holliday junction is effectively migrated. In the absence
of high-resolution structural information it remains un-
clear precisely how BLM carries out these activities.
The BLM protein also possesses activities it is not
known to share with RecG. BLM can act in concert with
EXO1 at double stranded DNA ends to cause a 50-30 single
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stranded resection that exposes a free ssDNA 30 end suit-
able for loading with Rad51 [17], reminiscent of the com-
bined activities of the E. coli RecQ helicase and RecJ 50-30
exonuclease [18,19]. Alternatively, BLM can also function-
ally interact with the DNA2 exonuclease to carry out a
similar reaction [20]. BLM has strong unwinding activity
on G-quadruplex DNA structures [21] as well as both
ssDNA annealing [22,23] and/or strand exchange activities
[24]. Notably, BLM has many well-characterized protein-
protein interactions, including those with RMI1, C16orf75
(RMI2) and TOP3A [25-28] that collectively mediate
double-Holliday junction dissolution, as well as direct
interaction with the Rad51 recombinase [29] and with the
multi-component Fanconi anemia protein containing
BRAFT complex [30]. In contrast, RecG functions in a
largely monomeric manner [31].
The mechanistic similarities between BLM and RecG have
led us and others [32] to speculate that E. coli RecG and
human BLM may be functional analogs. In order to test this
hypothesis and to determine the extent to which the shared
biochemical activities of BLM and RecG are responsible for
suppressing the functional cellular phenotypes observed in
human cells lacking BLM, we reasoned that suitable expres-
sion of RecG might suppress a BLM defect. The best charac-
terized cellular phenotype of BLM deficiency is a 10-fold
elevated frequency of sister chromatid exchanges [33],
thought to represent a hyper-recombination phenotype indi-
cative of elevated crossing-over and overall genomic instabil-
ity. In addition, we have recently demonstrated that BLM
deficiency causes a striking destabilization of the highly re-
petitive human ribosomal RNA gene clusters (the ‘rDNA’),
with recombination-mediated genomic restructuring of these
clusters increased 100-fold over cells wild-type for BLM
function [34]. Accordingly, we engineered several semi-
humanized RecG protein expression systems and stably
introduced these constructs into human cells either
wild-type or defective for the BLM protein. We then assayed
the resulting RecG transgene expressing cells for changes in
these two phenotypes.
Methods
Protein expression constructs
The coding sequence for RecG was isolated from E. coli
TOP10 (Invitrogen) genomic DNA with the addition of a
consensus Kozak sequence [35] and the SV40 large T-anti-
gen nuclear localization signal (PKKKRKV) by PCR using
primers 50-ggggggggatccagccaccatggctccaaaaaaaaagcgcaaag
tggcgatgaaaggtcgcctg and 50-gggggggatatcgcggccgcttacgc
attcgagta (RecG sequences underlined) followed by clon-
ing into the pCAGGS mammalian constitutive expression
vector. A cryptic polyadenylation sequence in the RecG
coding sequence 50-AATAAA (AsnLys) was removed via
silent mutagenesis to 50-AACAAG (AsnLys). Carboxy-
terminal additions of the enhanced green fluorescent
protein (EGFP) coding sequence were constructed either
to produce a RecG-EGFP fusion protein with a GSG
linker peptide (Figure 1A) “RecG fuse” (predicted mo-
lecular weight: 104.7 kDa), or to produce two proteins
in a bi-cistronic manner: RecG fused to the Strep-tag II
for potential affinity purification [36] followed by a
GSG linker, the 2A polyprotein ‘self-cleaving’ sequence
from Thosea asigna virus [37,38], a VAT peptide linker
and EGFP (Figure 1B) “RecG 2a”. In the bi-cistronic
construct the predicted molecular weight of the RecG
polypeptide is 80.8 kDa and the predicted molecular
weight of the EGFP polypeptide is 27.3 kDa. All final
construct sequences were verified by direct DNA se-
quencing. The finished constructs express essentially the
entirety of the wild-type E. coli RecG polypeptide, with
small amino- and carboxy-terminal extensions. The
EGFP expression vector used for subcloning the EGFP
coding sequence was pEGFP-N1 (Clontech). The RecG
expression constructs with full annotation are available
from the non-profit Addgene plasmid repository (http://
www.addgene.org) as plasmids #31274 and #31275.
Cell lines
Cell lines used that express normal BLM include the
SV40-transformed fibroblast line GM00637 (Coriell Cell
Repositories) “BLM+” and the cervical carcinoma line
HeLa S3 (ATCC: American Type Culture Collection)
“HeLa”. Cell lines used that are deficient in BLM protein
include GM08505 (Coriell Cell Repositories) which are
SV40 transformed fibroblasts derived from a Bloom syn-
drome patient homozygous for the Ashkenazi Jewish
founder BLM mutation (6-bp del/7-bp ins) at nucleotide
2281 of the open reading frame, hereafter referred to as
“BLM-”. A second BLM deficient line used was
GM16375 (Coriell Cell Repositories) which are EBV
transformed lymphocytes from a French-Canadian
Bloom syndrome patient homozygous for a C>A trans-
version resulting in a (S595X) termination mutation,
hereafter referred to as “BLM- FC”. The BLM-defective
line stably suppressed by either BLM cDNA expression,
or by a control empty vector are the lines PSNF5 “BLM-:
cDNA” and PSNG13 “BLM-: empty vector” respectively,
as described in [39] (kind gift from Ian Hickson) both
derived originally from the GM08505 line (Coriell Cell
Repositories). Lines were generally grown in MEM with
10% fetal bovine serum, with L-gln and antibiotic supple-
mentation at 37C in a humidified 5% CO2 incubator.
Stable cell lines were generated by electroporating either
a RecG expression construct or a control EGFP expression
construct into cells, followed by unselected cell population
expansion, one round of flow-sorting enrichment for
green fluorescent cells, further unselected expansion, and
finally a second round of flow-sorting enrichment for
green fluorescent cells. Clonal and subclonal derivatives of
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these highly enriched fluorescent populations were subse-
quently derived by limiting dilution. All of the transgene
expressing cell lines generated and used in this work are
either clonal or subclonal, with the exception of the
“BLM- FC: RecG fuse” line: BLM- FC cells were trans-
duced by a high-titer lentivirus (Welgen, Inc.) containing
an expression cassette for the RecG-EGFP fusion con-
struct (Figure 1A) and separated into green fluorescent
and non-fluorescent populations by flow sorting, and the
BLM-: EGFP line which was isolated on the basis of drug
resistance only. Stable cell lines were chosen for further
experiments on the basis of the levels of EGFP expressed
in these lines, as measured by flow cytometry.
Sister chromatid exchange assays
Sister chromatid exchange assays were performed largely
according to [40] with minor modifications [34]. Cellular
metaphase spreads were imaged and scored individually
by counting the number of visible exchanges and the
number of chromosomes in each unique high powered
microscope field to calculate the number of SCEs per
chromosome. In our hands, scoring the number of SCEs
per chromosome is more robust than scoring the num-
ber of SCEs per metaphase and is relatively insensitive
to the ploidy of the cell line under investigation [41].
The resulting SCEs/chromosome figures were binned
and plotted. All statistical tests were performed using
unbinned data. SCE experiments were generally per-
formed by collecting fixed metaphase cells from one or
two experiments, which were subsequently dropped on
microscope slides to release the metaphase spreads,
stained and counted together in a single session at the
microscope.
Western blotting
Protein extracts were prepared using RIPA buffer as
described previously [34]. All resolving SDS-PAGE gels
used 9% acrylamide and were blotted onto Hybond-ECL
nitrocellulose membrane (Amersham Biosciences, cat.
#RPN68D). Primary antibodies used were: rabbit anti-GFP
(Cell Signaling Technologies, cat. #2555), rabbit anti-beta-
actin (Cell Signaling Technologies, cat. #4970), rabbit
anti-beta-tubulin (NeoMarkers, cat. #RB-9249-PO). The
secondary antibody was ImmunoPure Antibody donkey
anti-rabbit IgG conjugated with horseradish peroxidase
(Pierce, cat. #31458). Blots were developed using an
Amersham™ ECL Plus western blotting detection system
(GE Healthcare, cat. #RPN2132) and imaged with a Storm
860 PhosphorImager (Molecular Dynamics).
GCI analysis
Gene cluster instability analysis was carried out as
described previously [34]. Briefly, genomic DNA was pre-
pared in the solid phase by digesting single cell suspen-
sions in agarose with proteinase K in the presence of
sarkosyl and EDTA, rinsed thoroughly and equilibrated in
50% glycerol/10 mM Tris/1 mM EDTA pH 8.0 and stored
at -20C. 10 μl agarose slices containing approximately 1
μg genomic DNA were equilibrated in suitable restriction
digestion buffer and digested overnight with EcoRV (New
England Biolabs). Digested DNA still in solid form was
loaded into a 1% PFC agarose (Bio-Rad) gel and run in
0.5× TBE buffer (44.5 mM Tris base, 44.5 mM boric acid,
1 mM EDTA pH 8.0) using a CHEF-MAPPER system
(Bio-Rad) at 14C. Pulsed-field electrophoretic conditions
were a field strength of 6 V/cm with 120° separation be-
tween field vectors. Field switch times varied from 3
Figure 1 RecG expression constructs. 1A) RecG expressed as a fusion protein with EGFP. Lettering colors: black: linker amino acids, red: nuclear
localization signal, blue: RecG coding sequence, green: EGFP coding sequence. 1B) RecG co-translated with EGFP as two separate polypeptides.
Lettering colors: black: linker amino acids, red: nuclear localization signal, blue: RecG coding sequence, brown: strep-tag II, purple: 2a ‘self-cleaving’
peptide, green: EGFP coding sequence. Dotted line represents the division of the precursor polyprotein into two independent polypeptides. The
full-length wild-type E. coli RecG polypeptide initiates with the indicated MKGR. . . peptide sequence and terminates with the indicated . . .YSNA
peptide sequence.
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seconds to 90 seconds with a ‘ramp factor’ of 0.357. Gels
were run for 24 hours, equilibrated to 0.5% glycerol in
water, then dried, rehydrated, probed with a radiolabeled
probe specific for the human rDNA [42] and imaged with
a Storm 860 PhosphorImager (Molecular Dynamics).
EGFP quantitation by flow cytometry
For cell lines carrying EGFP transgenes, the fold increase in
fluorescence relative to non-fluorescent cells was calculated
by dividing the geometric mean value of green fluorescence
emitted from the fluorescent cell sub-population by the
geometric mean value of background green autofluores-
cence from the non-fluorescent sub-population of the same
cell line.
Results
RecG expression suppresses the BLM- elevated SCE
phenotype
We stably transfected E. coli RecG expressing transgenes
into human cells with both BLM-defective and BLM-
normal genetic backgrounds. Two different expression
systems were used, a direct fusion protein between RecG
and EGFP, and a bi-cistronic system where separate RecG
and EGFP polypeptides are co-translated. RecG fusion
proteins in E. coli largely retain functionality [43], and in-
deed the RecG-EGFP fusion protein plasmid used in this
work increases the resistance of deletion recG E. coli to
mitomycin C (Robert Lloyd, personal communication).
We found a significant RecG dose-dependent decrease in
SCEs per chromosome in BLM- cells (Table 1, Figure 2)
with the highest level of RecG expression tested reducing
the elevation of SCEs by 75%. In our hands, expression of
the human BLM protein from a cDNA construct in BLM-
cells reduces this characteristic elevated SCE phenotype
by 80% (Figure 2A, Table 1 and [34]), so E. coli RecG ex-
pression is nearly as effective as the human protein in this
system. RecG suppressed the elevated BLM- SCE pheno-
type either when expressed as an EGFP fusion protein or
as a separate polypeptide co-translated with EGFP. In all
cases where RecG is expressed in a BLM- line, mean
SCEs/chromosome are reduced with high confidence
(two-tailed Mann–Whitney test, P<0.001). Expression of
EGFP alone without RecG in BLM- cells has no statisti-
cally significant effect on SCE levels (Figure 2A, Table 1).
That RecG suppression of the BLM- elevated SCE pheno-
type is not dependent on the genetic background of the
cells other than with respect to the loss of BLM is demon-
strated by manner in which RecG suppresses sister chro-
matid phenotypes both in cells of Ashkenazi Jewish origin
and separately in cells of French-Canadian origin
(Figure 3A). Both of these lines are essentially BLM-null
due to a 6-bp deletion/7-bp insertion, and due to an
S595X mutation respectively yet presumably have other-
wise heterogeneous genetic backgrounds. RecG is
expressed at a low level in “BLM- FC: RecG fuse” cells
(Figure 3B, Table 1), resulting in a less dramatic, 25%
reduction in the elevated SCE phenotype, nevertheless
in a statistically highly significant manner (P=0.0004,
Mann–Whitney two-tailed test).
RecG has no effect on SCE levels in cells expressing
normal BLM protein
In order to establish the BLM- specificity of the RecG SCE
reduction effect, we carefully examined SCE levels in two
different BLM+ lines that stably express relatively high
levels of either the RecG-EGFP fusion protein, or the bicis-
tronic RecG/EGFP construct (Figure 4). We found that
RecG expression had no statistically significant effect on
either the median levels of SCEs per chromosome or in the
distribution of SCEs seen in either BLM+ line (Table 1).
Loss of RecG expression restores the elevated SCE
phenotype to BLM- cells
One of the clonal BLM- lines stably expressing medium
levels of the RecG-EGFP fusion protein (Figure 5B, “BLM-:
RecG fuse med”) gradually lost EGFP expression during
two months of continuous cell culture in the absence of se-
lection, likely due to epigenetic silencing of the RecG-EGFP
transgene. In the resulting “BLM-: lost RecG fuse” line,
SCE levels were re-elevated to nearly those of either the
parental BLM- line, or the control BLM- line containing a
Table 1 SCE levels and EGFP expression
Cells SCE/Chr EGFP % EGFP+ HPF Xomes
HeLa 0.09 1.0 0 21 605
HeLa: RecG fuse 0.08 42.6 98 32 835
BLM+ 0.10 1.0 0 22 863
BLM+: RecG 2a 0.10 49.3 100 30 999
BLM-: cDNA 0.28 1.0 0 26 1625
BLM-: RecG 2a high 0.33 148 93 33 1861
BLM-: RecG fuse high 0.34 29.8 87 26 1149
BLM-: RecG 2a low 0.68 12.4 92 36 2017
BLM-: EGFP 1.02 27.3 57 48 3013
BLM-: empty vector 1.05 1.0 0 25 1354
BLM- 0.98 1.0 0 16 883
BLM- FC: RecG fuse 0.70 6.4 100 55 1981
BLM- FC 0.91 1.0 0 49 2077
BLM-: RecG fuse med 0.43 30.6 87 29 1925
BLM-: lost RecG fuse 0.86 8.96 1 25 1316
Cells: The stable cell line being investigated.
SCE/Chr: Median number of sister chromatid exchanges observed per
chromosome (sister chromatid pair).
EGFP: Relative levels of fluorescence for cells expressing RecG and/or EGFP,
relative to cells not expressing EGFP.
% EGFP+: The fraction of cells in a population with above-background green
fluorescence due to expression of EGFP.
HPF: The number of high powered microscope fields scored.
Xomes: The total number of sister chromatid pairs scored for exchanges.
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transgene for EGFP alone “BLM-: EGFP” (Figure 5A,
Table 1), confirming that RecG expression is solely respon-
sible for suppressing the elevated SCE phenotype in
BLM- cells.
RecG expression reduces the elevated gene cluster
instability (GCI) of BLM- cells
Loss of BLM very strongly increases the rate of spontan-
eous recombination-mediated genomic restructuring in
the highly repetitive human rRNA gene clusters [34]. In
BLM- cells, recombination alters gene cluster lengths on
the order of every round of mitotic cell division, an ap-
proximate 100-fold increase over the rate in BLM+ cells.
This rapid randomization of cluster lengths produces a
diagnostic ladder-like electrophoretic karyotype with
each rung on the ladder separated by the 48.5 kb unit
length of the human rDNA repeat, particularly in the
range of gene cluster lengths from 250 kb to 550 kb
(Figure 6 – shaded in red, red dotted side bracket). The
intensity of individual cluster bands is related to how
early in the clonal expansion the mitotic recombination
event took place, with more intense bands having arisen
earlier in the expansion of a clonal population [34]. Ex-
pression of RecG suppresses this elevated GCI pheno-
type: the rate of spontaneous cluster restructuring is
greatly reduced (Figure 6 – red carets) although as with
Figure 2 RecG expression suppresses the BLM- elevated SCE phenotype. 2A) Normalized sister chromatid exchange frequencies. “RecG 2a”
denotes cells expressing RecG and EGFP as separate co-translated proteins. “RecG fuse” denotes cells expressing RecG and EGFP together as a fusion
protein. 2B) Representative sister chromatid exchange metaphase spreads with sister chromatids differentially stained. The harlequin staining pattern
of the BLM- cells is greatly reduced upon expression of RecG. 2C) RecG expression levels. Protein extracts from the indicated cell lines are blotted with
an anti-GFP antibody and with anti-β-actin as a loading control. RecG-EGFP fusion proteins (105 kDa) are indicated with blue ovals. EGFP is detected
as a proxy biomarker for RecG in the “RecG 2a” co-translated lines. See also Table 1 for EGFP quantitation by flow cytometry.
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suppression of the elevated SCE phenotype of BLM-
cells, there is a residual low level of GCI even at the
highest levels of RecG expression assayed. Notably, ex-
pression of RecG is particularly effective at restabilizing
gene clusters in the previously highly unstable 250 kb to
550 kb size range, as seen by the significant reduction of
gene cluster lengths detected in this range. When GCI is
quantified by the average number of minor bands
Figure 3 RecG expression reduces SCE in a French-Canadian BLM- line. 3A: Normalized sister chromatid exchange frequencies. “BLM- FC”:
EBV-immortalized lymphocytes homozygous for an inactivating (S595X) mutation. “BLM- FC: RecG fuse”: the same cells expressing low levels of
the RecG-EGFP fusion protein. 3B: Western blot showing relative protein levels. Blue oval: RecG-EGFP fusion protein. “BLM- FC: RecG fuse”: protein
extract from French-Canadian BLM- cells stably expressing low levels of the RecG-EGFP fusion protein. “BLM- FC”: protein from French-Canadian
BLM- cells lacking a RecG transgene. See also Table 1 for EGFP quantitation by flow cytometry.
Figure 4 RecG expression has no effect on SCE levels in cells with normal BLM protein. Normalized sister chromatid exchange frequencies
are shown. Note the scale of the x-axis in this figure ranges from 0 to 0.2 for the distribution of SCEs/chromosome in lines with normal BLM
function, whereas the scale of the x-axis in Figure 2A ranges from 0 to 2.0 SCEs/chromosome, consistent with the known 10-fold elevation of
sister chromatid exchanges in BLM- lines.
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observed per clone [34], expression of RecG suppresses
the elevated BLM GCI phenotype by more than 3-fold
overall, from 8.7 minor bands per clone in the BLM-
cells to 2.6 minor bands per clone in the BLM- cells that
express RecG.
RecG expression does not affect gene cluster instability in
BLM+ cells
Expression of RecG as an independent polypeptide co-
translated with EGFP did not have an obvious effect on
gene cluster instability in a cell line wild-type for BLM
Figure 5 Loss of RecG expression in BLM- cells restores the elevated SCE phenotype. 5A) Normalized sister chromatid exchange
frequencies are shown. 5B) Loss of expression of RecG-fuse is shown by western blotting (blue ovals). See also Table 1 for EGFP quantitation by
flow cytometry.
Figure 6 RecG stabilizes the gene cluster instability of BLM- cells. Southern blotting detection of the rDNA clusters with resolution up to 1
Mb is shown. Cluster lengths are calibrated by S. cerevisiae chromosome size markers. Open star is the 1 Mb resolution limit of the gel: all clusters
larger than 1 Mb co-localize to this band. Clonal populations are shown on the left of each panel, with a collection of subclones derived from
this clonal population to the right. Red carets: mitotic recombination indicated by minor intensity gene cluster bands. The zone of particularly
high instability in the 250 kb to 550 kb size range is indicated by red shading and by the red dotted bracket at the right. 6A) “BLM-: RecG 2a
high”: BLM- cells stably expressing higher levels of cotranslated RecG/EGFP. 6B) The parental BLM- line from which the “BLM-: RecG 2a high” cells
were derived.
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protein (Figure 7) even though RecG is expressed at a
relatively high level when measured by flow cytometry
detection of the co-translated EGFP protein in this line
(Table 1: BLM+: RecG 2a). The changes to the banding
pattern in the subclones relative to that of the parental
clonal population represent mitotic recombination
events that occurred sufficiently late in the expansion of
the parental clonal population as to be undetectable as
visible minor-intensity banding. The relatively small
number of changes to major intensity bands in the sub-
clones and the lack of detectable minor bands in any of
the cell populations is consistent with the low levels of
spontaneous gene cluster restructuring seen in other
BLM+ transformed human cell lines [34].
Discussion
We show here that expression of the E. coli RecG protein is
able to largely, but not completely, suppress two functional
human cellular phenotypes of BLM deficiency: elevated
sister chromatid exchange, and elevated gene cluster in-
stability. Although this result is in accord with the several
shared biochemical activities of these two proteins, this
functional suppression across different kingdoms of biology
is interesting, particularly when considering that there
appears to be no relationship of evolutionary sequence
homology between RecG and BLM. Both RecG and BLM
are members of the DEXDc superfamily of helicase pro-
teins, and both contain both DEXDc and HELICc subdo-
mains (Figure 8 and [44]), however, the E. coli RecQ
protein is the clear evolutionary homolog of BLM on the
basis of sequence similarity within these two conserved
domains. The helicase family membership of RecG not-
withstanding, RecG does not primarily fulfill the classical
function of a helicase but rather seems to have co-opted
the molecular engine of a helicase to translocate on double
stranded DNA. We suggest that this manner of transloca-
tion may also be true of BLM particularly during the
branch migration of Holliday junctions since the crystal
structure of a Holliday junction shows minimal single-
stranded DNA character [45]. Both RecG and BLM have
extended amino acid sequences N-terminal to their
DEXDc superfamily domains and it is possible that signifi-
cant structure/function similarities to RecG may reside in
this region. Alternatively, BLM may maintain a portion of
the Holliday junction in transient single-stranded form as
Holliday junctions branch migrate together during junc-
tion dissolution.
The E. coli RecG protein, with essentially no sequence
similarity to human BLM, would seem unlikely to engage
in any of the well-characterized protein-protein interac-
tions that are important for function of the BLM protein
in the wild-type human cellular context, although we have
not experimentally ruled out these interactions. The cap-
acity with which RecG can suppress BLM- cellular pheno-
types suggests therefore that the physiological role of
BLM in suppressing the two phenotype we investigated,
sister chromatid exchanges and gene cluster instability, is
to perform the same molecular reactions that can be per-
formed in a human cell by the RecG monomer alone,
namely direct manipulations of DNA structures. This is
not to rule out a role for BLM and associated protein-
protein interactions in suppression of other manifestations
of genomic instability, or potentially BLM accessory pro-
teins may help localize BLM to DNA structures upon
which both BLM and RecG can act, thereby reducing the
required level of BLM in the cell relative to the large
amount of ectopic RecG expressed in the cell lines of this
study. Activities of BLM not known to be shared by RecG,
such as the unwinding of G-quadruplex DNA, must play a
minor role in both sister chromatid exchange and gene
cluster instability suppression assayed herein, or alterna-
tively, a G-quadruplex activity of RecG may remain to
be discovered.
Figure 7 RecG has no effect on gene cluster instability in cells
with normal BLM. Southern blotting detection of the rDNA clusters
in BLM+ cells stably expressing higher levels of co-translated RecG/
EGFP, “BLM+: RecG 2a”. Cluster lengths resolved up to 1 Mb are
shown. Cluster lengths are calibrated by S. cerevisiae chromosome
size markers. Open star is the 1 Mb resolution limit of the gel: all
clusters larger than 1 Mb co-localize in this region. A clonal cell
population is shown in the far left lane of the gel. A collection of
subclonal populations each derived from a single cell of this clonal
population are shown to the right. Plum circles: relocated major
band clusters. Blue braces: former location of major band clusters
from the parental clone.
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We suggest that RecG and BLM fulfill the same
physiological function in E. coli and human cells respect-
ively: they recognize stalled/regressed DNA replication
forks and then utilize their common biochemical func-
tions to mitigate this topological genomic damage. Given
the well-established biochemical similarities between the
two proteins and the capacity for RecG to functionally
substitute for BLM shown in this work, we consider this
the most parsimonious conclusion. Nevertheless, an al-
ternative possibility consistent with our data is that the
lesions recognized by BLM and RecG may be distinct
from each other, but that may be converted though sub-
sequent processing into a common form. For example,
human cells, lacking RecG, may over-produce the classic
substrate for RecG: a replication fork missing the nas-
cent leading strand which may then be converted, by
some as yet uncharacterized mechanism, into a bona
fide distinct substrate for the BLM protein. The converse
situation is also possible: that in the absence of BLM,
the lesion recognized by BLM is converted into a differ-
ent lesion that can be recognized and repaired by RecG.
An additional possibility is that the lesion recognized by
BLM and RecG may be the same, yet the two proteins
may convert the lesion to different, but still less genomi-
cally destabilizing alternative structures. Mechanistic
details aside, that the bacterial RecG protein can relieve
human genomic instability phenotypes resulting from
BLM protein deficiency demonstrates the highly
conserved nature of DNA structural lesions and the type
of mitigating enzymatic processing required to preserve
genomic stability.
The role of BLM in human genomic stabilization is
well-established. In contrast, a major mechanistic role of
RecG in E. coli genomic stabilization has only recently
been elucidated. In the absence of RecG, PriA initiates
spurious replication forks throughout the bacterial gen-
ome, causing poorly-controlled genomic over-replication
and compromised viability [46]. In the absence of RecG,
cells have an absolute requirement for a ssDNA exo-
nuclease activity, unless PriA is also eliminated [47]. It
will be interesting to determine whether human BLM-
cells share this over-replicated phenotype. Curiously, the
E. coli RecQ protein rather than protecting the cell from
aberrant recombination structures as the human BLM
and E. coli RecG proteins do, seems to act instead to
promote their formation [48]. Cells lacking the UvrD-
mediated inhibition of recombination and also lacking
RecG are killed by formation of intermolecular recom-
bination intermediates (IRIs) that interfere with correct
genome segregation to daughter cells. Formation of IRIs
is caused by the action of RecQ and partner proteins
and causes “death by recombination”. Deletion of RecQ
restores cellular viability [49]. An analogous phenotype
in human cells might be the elevated formation of ana-
phase bridges in cells deficient for BLM [50]. One evolu-
tionary interpretation consistent with our functional
Figure 8 Domain-based alignment of E. coli RecG and human BLM proteins. All conserved domain analysis below is from [44], RecG
accession GI:42669, BLM accession GI:4557365. RecG Conserved Domains: RecG_wedge_OBF: A subfamily of OB folds corresponding to the OB
fold found in the N-terminal (wedge) domain of Escherichia coli RecG. DEXDc: DEAD-like helicases superfamily. A diverse family of proteins
involved in ATP-dependent RNA or DNA unwinding. This domain contains the ATP-binding region. HELICc: Helicase superfamily c-terminal
domain; associated with DEXDc-, DEAD-, and DEAH-box proteins, yeast initiation factor 4A, Ski2p, and Hepatitis C virus NS3 helicases. PRK10917:
ATP-dependent DNA helicase RecG; Provisional BLM Conserved Domains: BDHCT: This is a C-terminal domain in Bloom’s syndrome DEAD helicase
subfamily. DEXDc: DEAD-like helicases superfamily. A diverse family of proteins involved in ATP-dependent RNA or DNA unwinding. This domain
contains the ATP-binding region. HELICc: Helicase superfamily c-terminal domain; associated with DEXDc-, DEAD-, and DEAH-box proteins, yeast
initiation factor 4A, Ski2p, and Hepatitis C virus NS3 helicases. RQC domain: This DNA-binding domain is found in the RecQ helicase among
others and has a helix-turn-helix structure. The RQC domain, found only in RecQ family enzymes, is a high affinity G4 DNA binding domain. HRDC
domain: The HRDC (Helicase and RNase D C-terminal) domain has a putative role in nucleic acid binding. recQ_fam: ATP-dependent DNA
helicase, RecQ family. All proteins in this family for which functions are known are 30-50 DNA-DNA helicases. These proteins are used for
recombination, recombinational repair, and possibly maintenance of chromosome stability. This family is based on the phylogenomic analysis of
JA Eisen (1999, Ph.D. Thesis, Stanford University).
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data here would be that although the ancient common
protein ancestor of both RecQ and BLM was preserved
in evolutionary descent through both lineages to provide
a core helicase domain, the functionality of these pro-
teins diverged in opposite directions. Since there are no
RecG homologs by sequence similarity in human cells, it
would appear that at least one of the five human RecQ
paralogs, BLM, has at least to some extent taken on the
important recombination molecular transactions pro-
vided to E. coli by the RecG protein, and is an example
of convergent evolution.
Conclusion
E. coli RecG and human BLM play similar, and to some
extent interchangeable, roles in suppressing genomic in-
stability phenotypes when expressed in human cells. Ac-
cordingly, given their lack of sequence homology, E. coli
RecG and human BLM may be an example of conver-
gent evolution.
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